Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2008-03-21 | Mr. Maier is currently an independent financial consultant. Previously, Mr. Maier was Senior Vice President and Chief Financial officer of Ligand Pharmaceuticals, Inc. Mr. Maier received an MBA from Harvard Business School and a BS from Pennsylvania State University. |
| 2009-03-30 | Mr. Maier is currently an independent financial consultant and has held senior financial positions in biotechnology and pharmaceutical companies. He received an MBA and a BS from Pennsylvania State University. |
| 2010-03-30 | Mr. Maier is currently an independent financial consultant. Since October 2009, he has been serving as Interim Chief Financial Officer of Sequenom, Inc., a publically held company serving the discovery, clinical research, and molecular diagnostics market. |
| 2011-03-30 | Mr. Maier’s director qualifications include his education, his experience and Board experience. Mr. Maier currently serves as Audit Committee Chair of two other Boards and Compensation Committee Chair on one of those Boards. |
| 2012-04-16 | Mr. Maier received an MBA from Harvard Business School and a BS from Pennsylvania State University. The Governance Committee believes that Mr. Maier’s director qualifications include his education and his experience and Board experience. |
| 2013-04-30 | Mr. Maier received an MBA from Harvard Business School and a BS from Pennsylvania State University. The Governance Committee believes that Mr. Maier’s director qualifications include his education and his financial and management experience and Board experience. |
| 2014-03-25 | Mr. Maier received an MBA from Harvard Business School and a BS from Pennsylvania State University. The Governance Committee believes that Mr. Maier’s director qualifications include his education and his financial and management experience and Board experience with life sciences companies. |
| 2015-03-31 | Mr. Maier received an MBA from Harvard Business School and a BS from Pennsylvania State University. |
| 2016-04-18 | Mr. Maier received an MBA from Harvard Business School and a BS from Pennsylvania State University. We believe Mr. Maier’s qualifications to serve on our Board include his extensive experience in financial management and his service on other boards. |
| 2017-04-28 | Mr. Maier received an MBA from Harvard Business School and a BS from Pennsylvania State University. We believe Mr. Maier’s qualifications to serve on our Board include his extensive experience in financial management and his service on other boards. |
| 2018-04-30 | Mr. Maier received an MBA from Harvard Business School and a BS from Pennsylvania State University. We believe Mr. Maier’s qualifications to serve on our Board include his extensive experience in financial management and his service on other boards, which brings valuable knowledge and insights to our Board. |
| 2019-04-30 | Mr. Maier received an MBA from Harvard Business School and a BS from Pennsylvania State University. He has over 25 years of experience as a senior executive in biotechnology and pharmaceutical companies, including CFO roles. |
| 2020-06-02 | Mr. Maier received an MBA from Harvard Business School and a BS from Pennsylvania State University. He has over 25 years of experience as a senior executive in biotechnology and pharmaceutical companies, including CFO roles. |
| 2021-04-29 | Paul V. Maier became a director in July 2007 and has over 25 years of experience as a senior executive in biotechnology and pharmaceutical companies. From November 2009 through his retirement in June 2014, he served as Chief Financial Officer of Sequenom, Inc., a publicly held company serving the discovery, clinical research, and molecular diagnostics market. |
| 2022-04-27 | Mr. Maier received an MBA from Harvard Business School and a BS from Pennsylvania State University. We believe Mr. Maier’s qualifications to serve on our Board include his extensive experience in financial management and his service on other boards, which brings valuable knowledge and insights to our Board. |
| 2023-04-28 | Mr. Maier received an MBA from Harvard Business School and a BS from Pennsylvania State University. We believe Mr. Maier’s qualifications to serve on our Board include his extensive experience in financial management and his service on other boards. |
| 2024-04-25 | Mr. Maier received an MBA from Harvard Business School and a BS from Pennsylvania State University. We believe Mr. Maier’s qualifications to serve on our Board include his extensive experience in financial management and his service on other boards. |
| Filing Date | Source Excerpt |
|---|---|
| 2008-11-26 | Paul V. Maier Mr. Maier is the chair of the Audit Committee and Compensation Committee ... Fees Earned or Paid in Cash ($) 19,500, Option Awards ($) 515,637, Total ($) 535,137. |
| 2009-11-25 | PAUL V. MAIER In November 2009, Mr. Maier was appointed interim Chief Financial Officer of Sequenom, Inc. ... Mr. Maier is the Chairman of the Audit Committee. ... Mr. Maier is the Chairman of the Compensation Committee. ... Director Compensation table shows Mr. Maier received total compensation of $115,658 in Fiscal 2009. |
| 2010-11-30 | Paul V. Maier Fees Earned or Paid in Cash $34,000, Stock Awards $61,812, Total Compensation $95,812. Mr. Maier is the Chairman of the Audit Committee and the Compensation Committee... Mr. Maier qualifies as an audit committee financial expert. |
| 2012-07-12 | Paul V. Maier Fees Earned or Paid in Cash ($) 55,250, Stock Awards ($) 27,398, Option Awards ($) - , All Other Compensation ($) - , Total Compensation ($) 82,648. Mr. Maier is the Chairman of the Audit Committee and the Compensation Committee. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-09